Illustration of the role of exosomes in diabetic cardiomyopathy (DCM). In response to diabetes, normal cardiomyocytes undergo pathological changes, leading to the release of detrimental exosomes. These exosomes carry specific microRNAs (miRNAs), such as m (IMAGE)

ELSP

Illustration of the role of exosomes in diabetic cardiomyopathy (DCM). In response to diabetes, normal cardiomyocytes undergo pathological changes, leading to the release of detrimental exosomes. These exosomes carry specific microRNAs (miRNAs), such as m

Caption

Illustration of the role of exosomes in diabetic cardiomyopathy (DCM). In response to diabetes, normal cardiomyocytes undergo pathological changes, leading to the release of detrimental exosomes. These exosomes carry specific microRNAs (miRNAs), such as miR-1, miR-133a, and miR-126, which have potential as biomarkers for diagnosing DCM, as well as miRNAs like miR-30d, miR-195, miR-21, and miR-208a, which are associated with disease progression and present therapeutic targets.

Credit

Azhar Anwar/Nanjing University, Jizheng Ma/ The Army Engineering University of PLA, Xin Yin/Nanjing University

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.